ANGPTL3 and atherosclerosis: Individuals heterozygous for ANGPTL3 had 41% lower odds of ASCVD, whereas individuals with complete ANGPTL3 deficiency had also reduced odds of myocardial infarction with no evidence of coronary atherosclerotic plaques [80, 81].